Remarkable reductions of PAKs in the brain tissues of scrapie-infected rodent possibly linked closely with neuron loss

Medical Microbiology and Immunology

Volumn 203, Issue 5, 2014, Pages 291-302

  Meng, Ge ^a   Tian, Chan ^b   Wang, Hui ^b   Xu, Yin ^b   Zhang, Bao Yun ^b   Shi, Qi ^b   Gao, Chen ^b   Chen, Cao ^b   Fan, Xue Yu ^b   Wang, Jing ^b   Xiao, Kang ^b   Ren, Ke ^b   Xue, Ming Ming ^a   Dong, Xiao Ping ^b,c  

^a INNER MONGOLIA MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

PAKs; Prion; Rac cdc42; Raf1; Scrapie

Indexed keywords

P21 ACTIVATED KINASE 1; P21 ACTIVATED KINASE 3; PROTEIN CDC42; RAC PROTEIN; RAF PROTEIN; P21 ACTIVATED KINASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN HOMOGENATE; BRAIN NERVE CELL; BRAIN TISSUE; CELL LOSS; CEREBELLUM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REDUCTION KINETICS; REVIEW; SCRAPIE; SIGNAL TRANSDUCTION; SYRIAN HAMSTER; UPREGULATION; WESTERN BLOTTING; ANIMAL; BRAIN; CELL LINE; CRICETULUS; GENE EXPRESSION PROFILING; MOUSE; NERVE CELL; PATHOLOGY; TIME;

ANIMALS; BLOTTING, WESTERN; BRAIN; CDC42 GTP-BINDING PROTEIN; CELL LINE; CRICETULUS; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MICE; NEURONS; P21-ACTIVATED KINASES; PROTO-ONCOGENE PROTEINS C-RAF; SCRAPIE; TIME FACTORS;

EID: 84919494649     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-014-0342-5     Document Type: Review

References (38)

1. Prusiner SB (1991) Molecular biology of prion diseases. Science 252(5012):1515–1522
2. Relano-Gines A, Gabelle A, Hamela C, Belondrade M, Casanova D, Mourton-Gilles C, Lehmann S, Crozet C (2013) Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases. PLoS Pathog 9(8):e1003485. doi:10.1371/journal.ppat.1003485
3. Arias-Romero LE, Chernoff J (2008) A tale of two Paks. Biol Cell 100(2):97–108. doi:10.1042/BC20070109
4. Eswaran J, Soundararajan M, Knapp S (2009) Targeting group II PAKs in cancer and metastasis. Cancer Metastas Rev 28(1–2):209–217. doi:10.1007/s10555-008-9181-4
5. Kelly ML, Chernoff J (2012) Mouse models of PAK function. Cell Logist 2(2):84–88. doi:10.4161/cl.21381
6. Jaffer ZM, Chernoff J (2002) p21-Activated kinases: three more join the Pak. Int J Biochem Cell Biol 34(7):713–717
7. Carlisle HJ, Kennedy MB (2005) Spine architecture and synaptic plasticity. Trends Neurosci 28(4):182–187. doi:10.1016/j.tins.2005.01.008
8. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L (1994) A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367(6458):40–46. doi:10.1038/367040a0
9. Manser E, Huang HY, Loo TH, Chen XQ, Dong JM, Leung T, Lim L (1997) Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 17(3):1129–1143
10. Delorme V, Machacek M, DerMardirossian C, Anderson KL, Wittmann T, Hanein D, Waterman-Storer C, Danuser G, Bokoch GM (2007) Cofilin activity downstream of Pak1 regulates cell protrusion efficiency by organizing lamellipodium and lamella actin networks. Dev Cell 13(5):646–662. doi:10.1016/j.devcel.2007.08.011
11. Field J, Manser E (2012) The PAKs come of age: celebrating 18 years of discovery. Cell Logist 2(2):54–58. doi:10.4161/cl.22084
12. Arias-Romero LE, Villamar-Cruz O, Huang M, Hoeflich KP, Chernoff J (2013) Pak1 kinase links ErbB2 to beta-catenin in transformation of breast epithelial cells. Cancer Res 73(12):3671–3682. doi:10.1158/0008-5472.CAN-12-4453
13. Tian C, Liu D, Sun QL, Chen C, Xu Y, Wang H, Xiang W, Kretzschmar HA, Li W, Chen C, Shi Q, Gao C, Zhang J, Zhang BY, Han J, Dong XP (2013) Comparative analysis of gene expression profiles between cortex and thalamus in Chinese fatal familial insomnia patients. Mol Neurobiol 48(1):36–48. doi:10.1007/s12035-013-8426-6
14. Guo Y, Gong HS, Zhang J, Xie WL, Tian C, Chen C, Shi Q, Wang SB, Xu Y, Zhang BY, Dong XP (2012) Remarkable reduction of MAP2 in the brains of scrapie-infected rodents and human prion disease possibly correlated with the increase of calpain. PLoS One 7(1):e30163. doi:10.1371/journal.pone.0030163
15. Wang H, Tian C, Xu Y, Xie WL, Zhang J, Zhang BY, Ren K, Wang K, Chen C, Wang SB, Shi Q, Shao QX, Dong XP (2013) Abortive cell cycle events in the brains of scrapie-infected hamsters with remarkable decreases of PLK3/Cdc25C and increases of PLK1/Cyclin B1. Mol Neurobiol. doi:10.1007/s12035-013-8455-1
16. Xu Y, Tian C, Wang SB, Xie WL, Guo Y, Zhang J, Shi Q, Chen C, Dong XP (2012) Activation of the macroautophagic system in scrapie-infected experimental animals and human genetic prion diseases. Autophagy 8(11):1604–1620. doi:10.4161/auto.21482
17. Martin H, Mali RS, Ma P, Chatterjee A, Ramdas B, Sims E, Munugalavadla V, Ghosh J, Mattingly RR, Visconte V, Tiu RV, Vlaar CP, Dharmawardhane S, Kapur R (2013) Pak and Rac GTPases promote oncogenic KIT-induced neoplasms. J Clin Investig 123(10):4449–4463. doi:10.1172/JCI67509
18. Peippo M, Koivisto AM, Sarkamo T, Sipponen M, von Koskull H, Ylisaukko-oja T, Rehnstrom K, Froyen G, Ignatius J, Jarvela I (2007) PAK3 related mental disability: further characterization of the phenotype. Am J Med Genet Part A 143A(20):2406–2416. doi:10.1002/ajmg.a.31956
19. Selyunin AS, Sutton SE, Weigele BA, Reddick LE, Orchard RC, Bresson SM, Tomchick DR, Alto NM (2011) The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold. Nature 469(7328):107–111. doi:10.1038/nature09593
20. Sun H, King AJ, Diaz HB, Marshall MS (2000) Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Curr Biol 10(5):281–284
21. Huang W, Zhou Z, Asrar S, Henkelman M, Xie W, Jia Z (2011) p21-Activated kinases 1 and 3 control brain size through coordinating neuronal complexity and synaptic properties. Mol Cell Biol 31(3):388–403. doi:10.1128/MCB.00969-10
22. Ma QL, Yang F, Calon F, Ubeda OJ, Hansen JE, Weisbart RH, Beech W, Frautschy SA, Cole GM (2008) p21-Activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis. J Biol Chem 283(20):14132–14143. doi:10.1074/jbc.M708034200
23. Arias-Romero LE, Chernoff J (2010) p21-activated kinases in Erbb2-positive breast cancer: a new therapeutic target? Small GTPases 1(2):124–128. doi:10.4161/sgtp.1.2.14109
24. Boyce KJ, Schreider L, Andrianopoulos A (2009) In vivo yeast cell morphogenesis is regulated by a p21-activated kinase in the human pathogen Penicillium marneffei. PLoS Pathog 5(11):e1000678. doi:10.1371/journal.ppat.1000678
25. Dorrance AM, De Vita S, Radu M, Reddy PN, McGuinness MK, Harris CE, Mathieu R, Lane SW, Kosoff R, Milsom MD, Chernoff J, Williams DA (2013) The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment. Blood 121(13):2474–2482. doi:10.1182/blood-2012-10-460709
26. Gardiner J, Marc J (2011) Arabidopsis thaliana, a plant model organism for the neuronal microtubule cytoskeleton? J Exp Bot 62(1):89–97. doi:10.1093/jxb/erq278
27. Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE, Weisbart RH, Teter B, Frautschy SA, Cole GM (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci 9(2):234–242. doi:10.1038/nn1630
28. Choi WS, Palmiter RD, Xia Z (2011) Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model. J Cell Biol 192(5):873–882. doi:10.1083/jcb.201009132
29. Wang GR, Shi S, Gao C, Zhang BY, Tian C, Dong CF, Zhou RM, Li XL, Chen C, Han J, Dong XP (2010) Changes of tau profiles in brains of the hamsters infected with scrapie strains 263K or 139 A possibly associated with the alteration of phosphate kinases. BMC Infect Dis 10:86. doi:10.1186/1471-2334-10-86
30. Zhou RM, Jing YY, Guo Y, Gao C, Zhang BY, Chen C, Shi Q, Tian C, Wang ZY, Gong HS, Han J, Xu BL, Dong XP (2011) Molecular interaction of TPPP with PrP antagonized the CytoPrP-induced disruption of microtubule structures and cytotoxicity. PLoS One 6(8):e23079. doi:10.1371/journal.pone.0023079
31. Wang SB, Shi Q, Xu Y, Xie WL, Zhang J, Tian C, Guo Y, Wang K, Zhang BY, Chen C, Gao C, Dong XP (2012) Protein disulfide isomerase regulates endoplasmic reticulum stress and the apoptotic process during prion infection and PrP mutant-induced cytotoxicity. PLoS One 7(6):e38221. doi:10.1371/journal.pone.0038221
32. Dong CF, Shi S, Wang XF, An R, Li P, Chen JM, Wang X, Wang GR, Shan B, Zhang BY, Han J, Dong XP (2008) The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Arch Biochem Biophys 470(1):83–92. doi:10.1016/j.abb.2007.11.007
33. Li X, Dong C, Shi S, Wang G, Li Y, Wang X, Shi Q, Tian C, Zhou R, Gao C, Dong X (2009) The octarepeat region of hamster PrP (PrP51-91) enhances the formation of microtubule and antagonize Cu(2+)-induced microtubule-disrupting activity. Acta Biochim Biophys Sin 41(11):929–937
34. Li XL, Wang GR, Jing YY, Pan MM, Dong CF, Zhou RM, Wang ZY, Shi Q, Gao C, Dong XP (2011) Cytosolic PrP induces apoptosis of cell by disrupting microtubule assembly. J Mol Neurosc 43(3):316–325. doi:10.1007/s12031-010-9443-9
35. Delorme-Walker VD, Peterson JR, Chernoff J, Waterman CM, Danuser G, DerMardirossian C, Bokoch GM (2011) Pak1 regulates focal adhesion strength, myosin IIA distribution, and actin dynamics to optimize cell migration. J Cell Biol 193(7):1289–1303. doi:10.1083/jcb.201010059
36. Ye DZ, Field J (2012) PAK signaling in cancer. Cell Logist 2(2):105–116. doi:10.4161/cl.21882
37. Kumar R, Gururaj AE, Barnes CJ (2006) p21-Activated kinases in cancer. Nat Rev Cancer 6(6):459–471. doi:10.1038/nrc1892
38. Aksamitiene E, Achanta S, Kolch W, Kholodenko BN, Hoek JB, Kiyatkin A (2011) Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells. Cell Signal 23(11):1794–1805. doi:10.1016/j.cellsig.2011.06.014